Zanubrutinib Plus BR in Newly Diagnosed Symptomatic WM
Clinical trial NCT05914662 · RECRUITING
Trial details
- NCT number
- NCT05914662
- Sponsor
- Institute of Hematology & Blood Diseases Hospital, China
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-15
- Primary completion
- 2025-03-15
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.